Urinary Kim-1 is a sensitive biomarker for the early stage of diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats

Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients

(2012) Sang Soo Kim et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Kidney Injury Biomarkers in Hypertensive, Diabetic, and Nephropathy Rat Models Treated with Contrast Media

(2012) Rodney L. Rouse et al.   TOXICOLOGIC PATHOLOGY

Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes

(2011) F. L. Nauta et al.   DIABETES CARE

Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy

(2011) Tim Fugmann et al.   KIDNEY INTERNATIONAL

Vanin-1; a potential biomarker for nephrotoxicant-induced renal injury

(2011) Keiko Hosohata et al.   TOXICOLOGY

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States

(2010) Carol E. Koro et al.   CLINICAL THERAPEUTICS

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

(2010) S. E. Nielsen et al.   DIABETIC MEDICINE

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase

(2010) Vishal S. Vaidya et al.   KIDNEY INTERNATIONAL

Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons

(2009) Takashige Kuwabara et al.   KIDNEY INTERNATIONAL